Children on the autism spectrum often suffer from other medical conditions. As many as one-fifth of those diagnosed with the neurodevelopmental disorder, which affects communication and behavior, have epilepsy, for example, according to research on the subject. Probably Genetic, which recently graduated from the startup accelerator Y Combinator, wants to test the DNA of children with autism to provide them early diagnoses of more than 15 severe genetic diseases that are often grouped under the initial autism diagnosis. Using machine learning and direct-to-consumer DNA tests, Probably Genetic hopes to provide families of children on the spectrum with more complete and correct diagnoses and a path to appropriate treatment and therapy. "There is really low awareness still in the medical community for a lot of these diseases," Probably Genetic co-founder and chief executive officer Lukas Lange tells TechCrunch.